Showing results (291-300 of 610) with videos related to
Sort By:
Pageof 61
The Journal of Clinical Investigation|December 1, 1981
Responder cells in the human autologous mixed lymphocyte reactionJ S Smolen, T A Luger, T M Chused, et al.The Journal of Investigative Dermatology|April 1, 1994
UVB light induces nuclear factor kappa B (NF kappa B) activity independently from chromosomal DNA damage in cell-free cytosolic extractsM M Simon, Y Aragane, A Schwarz, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 1, 2006
[Current situation of dermatologic surgery in Germany]Peter Hensen, Marcel L Müller, Johannes Petres, et al.Sexually Transmitted Infections|August 7, 2003
Chlamydial infection: an accurate model for opportunistic screening in general practiceV Verhoeven, D Avonts, A Meheus, et al.International Journal of Epidemiology|September 1, 1988
Birthweight and socioeconomic status: a study in Kigali, RwandaM van Sprundel, A Buvé, A Serufilira, et al.The British Journal of Dermatology|April 16, 1998
Psoriasis vulgaris treated successfully with mycophenolate mofetilM G Haufs, S Beissert, S Grabbe, et al.Klinische Monatsblatter Fur Augenheilkunde|November 1, 1985
[Corneal epithelial cells and human conjunctival cell line (Chang) produce an interleukin 3-like factor]G Grabner, J Schreiner, T A Luger, et al.Infection and Immunity|December 1, 1982
Increased thymocyte-activating factor in human gingival fluid during gingival inflammationJ A Charon, T A Luger, S E Mergenhagen, et al.The Journal of Investigative Dermatology|August 17, 2006
Melanocortin receptor ligands: new horizons for skin biology and clinical dermatologyMarkus Böhm, Thomas A Luger, Desmond J Tobin, et al.Endocrine Research|February 1, 1994
The non ergot D2-dopamine agonist CV 205-502 decreases growth hormone concentrations in acromegalic patientsT Svoboda, H Kotzmann, M Clodi, et al.Pageof 61